Mode
Text Size
Log in / Sign up
N/A N=81 Randomized

Evaluation of a Dual Action Pneumatic Compression Device: Patient Ease of Use and Comfort

Chronic Venous Insufficiency

Enrolled (actual)
81
Serious AEs
0.0%
Results posted
Dec 2016
Primary outcome: Primary: Ease of Use and Comfort for Subjects Using the ACTitouch System. — 70.8; 37.5; 89.2; 59.4 Percent of participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Dual Action Pneumatic Compression Device (Device); Standard Compression Garments (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Tactile Medical
Primary completion
Jul 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Ease of Use and Comfort for Subjects Using the ACTitouch System.
70.8; 37.5; 89.2; 59.4; 70.8; 57.8

Summary

The purpose of this study is to determine the ease of use and comfort of the ACTitouch dual action pneumatic compression device in patients with unilateral or bilateral chronic venous insufficiency (CVI) with or without venous leg ulcers, as compared to standard compression.

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of unilateral or bilateral CVI with or without leg ulcers
  • Documented history of low adherence to compression garment therapy
  • CEAP classification C3-C6
  • Leg circumferences within the following ranges: Ankle 12-44cm, calf 22-6m, below the knee 22-68cm

Exclusion Criteria

  • History of skin sensitivity to any of the components of ACTitouch or compression garments
  • History of acute (deep vein thrombosis) DVT or (pulmonary embolism) PE within the last 3 months
  • Ankle Brachial Index (ABI) 10%
  • Exhibits any condition which, according to the PI, justifies the subjects exclusion from the study, such as a medical condition where an increase in venous or lymphatic return is undesirable.
  • Subjects with open ulcers must be able to follow their care regimen for ulcer healing concurrently with the assigned study regimen.
  • Participating in another clinical trial
  • Changes to medications that affect edema within the last 30 days
  • Currently pregnant or trying to become pregnant
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02015221). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search